Commercial Pricing and Contracting 101
|
|
- Cecil Jackson
- 6 years ago
- Views:
Transcription
1 Commercial Pricing and Contracting 101 Reimbursement and Contracting CBI Conference Philadelphia, PA February 4, 2016 Althea Danzey, Director of Contracting Tina Still, Senior Manager of Contracting Eisai Inc.
2 Disclaimer The views/observations expressed in this deck are the personal views/observations of the speakers and do not reflect the views/observations of Eisai Inc. 2
3 Agenda I. Introductions II. Topics to be Covered: Breakdown Contract Structure and Strategy Best Approaches to Contracting Operationalize a Program/Process How to Communicate Value to Commercial Payers Analysis of a Successful Negotiation How to Measure Success in Contracting III. Questions 3
4 Contract Structure & Strategy 4
5 Contracting Philosophy Contracting is a by-product of a business partnership that results in a mutually beneficial arrangement between the Manufacturer and the Contract Organization Contracting IS NOT: Getting the biggest discount for my customer Giving the account what they asked for Offering the maximum allowable rebate/discount to the account Contracting IS: A process of learning about your customer Finding a business solution that provides fair value and meets the needs of all parties Offering the right rebate/discount to secure the business partnership 5
6 Commercial Contracting Segments Commercial Contracting Segments: Managed Care Commercial, HIX & Medicare Part D Group Purchasing Organizations Integrated Delivery Networks Specialty Pharmacies 6
7 Pricing & Contracting Strategy Goals Pricing and Contracting Strategies provide a unique opportunity to leverage the brand imperatives within your organization: Provide access and remove barriers for patients Create and increase Market Awareness Promote growth 7
8 Pricing Considerations Product Life Cycle Considerations: Newly launched Loss of Exclusivity date Established Product Competitive Environment/ Landscape Contract Organizations MCO vs. Med D, GPO vs. IDN Product Market Buy and Bill vs. Retail Legislative Impact ACA, 340B, Government Pricing AMP, ASP, BP Barriers vs. Opportunities 8
9 Contracting Considerations Annualized sales volume and number of lives in contracted account Account s ability to drive market share of product Current utilization patterns in contracted account Impact on Metropolitan Statistical Areas(MSAs) or Nation of being off / on formulary Proposed formulary positioning and contracts relative to competition. For example, Copay differential or Tier level Position on formulary PA / Step-edits used Other competitive capabilities Contracted account s view of the product and market/class Align contracting with sales representatives deployment 9
10 Best Approaches to Contracting 10
11 Contract Management Life Cycle Brand Strategy Contract Strategy Contract Performance & ROI Access Opportunity Identified (i.e. GPO, Payors, Medicaid) Contract Pull Through Contract Discussions & Offer Analysis Begins Contract Rollout & Implementation Contract Negotiations Occur Contract Execution 11
12 Contracting Best Practices Standardize Your Process Ensure Account Management & Sales are educated, informed and have appropriate tools Monitor Performance and ROI Accurate tracking and calculation of incentives Assess ROI of contract offers Build compliance management into your process Establish Guidelines and formalize Exception Process Establish SWPs and update as needed Create an online repository for contracts, terms and frequently used clauses 12
13 Best Practices Standardize Your Processes Standardize your processes within the Contract Management Life Cycle Offer Analysis & Submission Develop models for Offer Analysis Establish Offer Review Process and Approvers Contract Negotiation & Execution Define Roles (Contracting, Legal and Account Management) Terms and Conditions (Acceptable vs. Exceptions) Contract Rollout and Implementation Define key activities that must occur Define roles and leads for implementation and rollout Establish timelines for implementation Contract Pull Through Define roles (Sales, Account Management) Determine goals and gain agreement across stakeholders Determine activities for successful pull through Establish communication plan and metrics to identify challenges, wins 13
14 Best Practices Educate Educate the key internal stakeholders within the organization: Brand Market Access Field Sales Organization Sales Training Trade Relations Contract Administration Finance Provide the appropriate tools to support assessment of opportunity and successful pull-through 14
15 Best Practices Process Flow The goal is to create a process that follows each contract offer from discussion to execution to evaluation. Define Opportunity Account Managers (AM) Customer Discussions held AM compiles pertinent information (product specifics, size, formulary, copay structure, requested offer, placement, terms etc.) AM discusses recommendation and gains approval Conduct Offer Analysis AM compiles data in scoring model/offer Analysis and submits to Contracting AM schedules conference call with Contract Manager (CM) to discuss Customer CM reviews analysis and seeks approvals Submit Offer CM Prepares Offer (Bid, LOI) CM Submits Offer to AM or directly to Customer. AM Follows up with the Customer to see if Offer has been accepted. AM Communicates status to CM Negotiate Agreement If Bid/LOI is accepted, CM drafts agreement CM Submits Agreement to Customer & AM CM negotiates Redlines with Customer Execute Agreement Customer Submits agreement for Execution CM scans and sends executed agreement to Legal and Contract Administration Contract Performance CM Evaluates Contract Performance Quarterly CM Set up discussion with AM to discuss contract performance 15
16 Define Opportunity Define Opportunity AM participates in discussion with Customer AM compiles pertinent information (product specifics, size, formulary, copay structure, requested offer, placement, terms etc.) AM discusses recommendation and gains approval When meeting with the Customer below are examples of the information that should be compiled: When is the bid due? What Products are they interested in? Customer Size: Total number of members, commercial lives, Part D lives, etc. Formulary Structure/ Formulary Design information (Managed Care) Primary Class of Trade (GPO) Is the Customer affiliated with a larger PBM? What is the General structure for Tiers? Tier 1, Tier 2, Tier 3, Preferred, Non-Preferred, Generic, Specialty etc. What is the co-pay cost per tier? Are there any barriers or restrictions? (PA, QL etc.) What is the Impact if we don t bid? (Will we fall to a lower tier? will we be blocked? Will a competitor be preferred?) If looking for a 1 of 2 preferred brand offering, where will remaining medications be placed? (i.e.. T3 vs. T2?) Standard or Rider benefit? 16
17 Conduct Offer Analysis Conduct Offer Analysis AM compiles data in scoring model/offer Analysis and submits to Contracting AM schedules conference call with Contract Manager (CM) to discuss Customer CM reviews analysis and seeks approvals Using the information the AM compiled from their meeting with the Customer, tell the story of the Customer in a Scoring Model/Offer Analysis Form. The Model will be a mixture of qualitative and quantitative questions. The more information provided in the model the easier it will be for Contracting decisions to be made. The Model will also assist with post contract evaluations and future contract strategies. Once the model has been submitted the to Contracting, schedule a time to speak with your AM Discussion topics can include opportunity, recommendation, timelines, terms, barriers, Manufacturer paper vs. Customer paper, the model, next steps etc. CM will prepare the background, recommendation and rationale and meet with Management to discuss the opportunity and gain approval. 17
18 Scoring Model Design and Intent Designed to organize critical information for each Customer into a standardized format Designed to evaluate the relative level of control or influence each Customer has on pharmaceutical prescriptions for its covered lives Designed to focus contracting initiatives around those market factors that the Manufacturer values most highly for any given product Designed to maintain consistency and auditability when contracting with like entities Designed to establish a partnership between Account Management and Contracting to develop a contract that provides the best business solution for the Customer and the Manufacturer Collaborative effort: Account Management, P&C, Brand, etc... One size does not fit all All contracts must fit with the overall contract guidelines 18
19 Scoring Model Collected Information Account Classification: How much control does a customer have over its plans or clients, how can it drive utilization, how many lives under management Formulary Details: Where is the Manufacturer s and competitive products on formulary including: restrictions, tier and copay differentials, prior authorizations, step edits, etc Account Assessment: Free form text for Account Management to detail their customer intelligence including: RFP details, customer meetings and/or discussions, customer requests, etc Contract Recommendation: Free form text for Account Management to quantify impact to achievement of the product strategic objectives Approved Guidelines: Included to permit Account Management and Contracting leadership to see the recommendation as well as approved ranges 19
20 Offer Analysis Design and Intent Supportive tool to provide assistance and provoke thought and discussion Designed to engage Account Management and P&C in discussions and financial impact Designed to provide Account Management with tool to support understanding of impact of offer to business Designed to create opportunity for discussion internally as to potential barriers, challenges and opportunities for growth 20
21 Submit Offer-Bid/Letter of Intent (LOI) Submit Offer CM Prepares Bid/LOI CM Submits Bid/LOI to AM or directly to Customer. AM Follows up with the Customer to see if Bid/LOI has been accepted. AM Communicates status to Contract Manager Within X Days of recommendation approval CM Prepares the Bid/LOI to include: Contract Type Product Terms Length of Agreement Bid/LOI must be accepted prior to contract agreement can be supplied to Customer CM submits Bid/LOI and copies AM AM should follow up with the Customer as to the status of the Bid/LOI. If the Bid/LOI has been rejected, AM should get as much detail as to why the bid was rejected and communicate this back to the CM. This will help us with future offerings. 21
22 Negotiate Agreement Negotiate Agreement If Bid/LOI is accepted, CM drafts agreement CM Submits Agreement to Customer & AM CM negotiates Redlines with Customer Once Bid/LOI is accepted, CM will draft agreement. If the Customer would prefer the agreement to be on their paper, Customer will submit an agreement to be redlined by CM within x business days. If the Customer is ok with the agreement being on Manufacturer paper, CM will use template to draft agreement and submit to Customer within x business days. When CM is done with redlines/template, they will submit the agreement for legal review within x business days. Once legal review is complete, agreement is submitted to Customer for their review. This step is repeated for as many versions of redlines are submitted between the two Customers 22
23 Execute Agreement Execute Agreement Customer Submits agreement for Execution CM scans and sends executed agreement to Legal and Contract Administration After all redlines have been finalized, CM will submit the agreement to Customer for execution. ( x Business Days) Customer signs then Dir. Of Contracting signs Executed agreement is scanned, saved and sent to Legal, Contract Administration and the Customer. ( x Business Days) AM is copied on the executed agreement CM logs the terms of the agreement in our contract tracking database Contract Administration Loads Terms into contracting system and notifies appropriate parties (i.e.. Wholesalers) 23
24 Operationalize Processes/Procedures 24
25 Contract Management/Authoring Tool Investigate opportunity for on-line contract management or authoring tool Why? Provides oversight of the entire contract process from request to execution to post-execution Allows for easy access to important terms and conditions Single repository to track redlines and manage version control Increased efficiencies and support KPIs within the department Facilitates reporting and compliance 25
26 Communicating Value to Payers 26
27 The Value Proposition The number one factor that is overlooked when developing a pricing strategy is coming up with a value proposition that can be used when selling to the payer Often the manufacturer will craft a value proposition to the prescribing physician but if it s not on formulary then the doctor may not prescribe the drug Price, value and medical necessity can determine whether or not your product is placed on formulary If the payer doesn t see the value in a drug, it may become a barrier to whether or not it gets prescribed Crafting a message that includes the clinical and economic need, addressing the health policy and shaping the patient experience. This will require working with your Brand, Account Management and HEOR teams 27
28 Analysis of Successful Negotiation 28
29 Successful Negotiation Be Prepared and Informed Know your Customer Know Your Product Know the Competitive Landscape Show Value Seek input for Internal Experts HEOR MSLs 29
30 Measuring Contract Success 30
31 Contract Performance Contract Performance CM Evaluates Contract Performance Quarterly CM Set up discussion with AM to discuss contract performance Using Rebate submitted data and the initial Scoring Model/Offer Analysis, CM will perform quarterly evaluations on contract performance to determine how the contract is doing when compared to the initial offer analysis. Review Formulary Coverage CM will review contract performance and will set up quarterly business reviews with respective teams to discuss performance and open opportunities 31
32 Importance of Tracking Performance Tracking results in the market place is key to measure the success strategy Are you getting what you promised you would when you implemented the contract? How is your formulary access with the payers? Are you seeing market share uptake? Are you seeing volume uptake Tracking results will educate and inform key stakeholders on contract performance Brand Market Access Sales Finance Tracking results will initiate discussions re: barriers, challenges, opportunities Key factor with performance metrics updates is to ensure they are utilized and provide value 32
33 Key Components to Success Partnership Value Compliance Efficiency 33
34 Ensure Partnership There are several key partners to consider when developing a contracting strategy. Manufacturer Physician Payer Pharmacy Distributor Patient Failing to look at contracting strategically from the point of view of each partner may result in errors that will impact the effectiveness of your strategy. 34
35 Interaction with Key Stakeholders Contract Development Government Pricing & Regulations Contract Administration Chargebacks Legal Trade Relations Finance Contracting Decisions will cause a ripple effect on other areas It s important to understand the impact prior to implementing any new contracting Strategy 35
36 Demonstrate Value Internally It is important to also demonstrate value internally within your organizations Define the value that access thru Contracting provides: First and foremost: Clinical Value Providing medicines to patients Improving quality of life Supports financial goals of the organization to continue to provide access to products that add value to consumers Share the value message through: Lunch and Learns Intranet Sales or Brand Meetings Stay informed about your product Attend advocacy events Interact with patients, families, and caregivers 36
37 Compliance Measures Establishing Contracting Guidelines will provide compliance measures within your organization: Guidelines are designed to: Support business sales, share targets Minimize financial exposure Minimize legal risk Establish SWPs for your processes and review and update regularly Stay informed regarding changes in legislation Partner with Legal & Government Affairs 37
38 Establish Efficiencies Establishing efficiencies is integral to a successful rollout and implementation of a contracting strategy Review and Revise your contract management life cycle Identify gaps and develop process efficiencies that are: 1) Effective; 2) Meaningful and 3) Supported If done right efficiencies can: Reduce redundancies Mitigate barriers t0 pull-through Support effective communication 38
39 Questions? 39
40 Contact Info Althea Danzey Director, Contracting Eisai Inc. Tina Still Senior Manager, Contracting Eisai Inc. 40
Optimize Government Pricing Agreements for Maximum Returns
Optimize Government Pricing Agreements for Maximum Returns 19 th Annual Medicaid and Government Pricing Congress We partner with our clients in the Life Sciences & Healthcare industries to provide direct
More informationEXAMINE THE BREAKDOWN OF FEES IN MANAGED MARKETS AND SPECIALTY PHARMACIES
EXAMINE THE BREAKDOWN OF FEES IN MANAGED MARKETS AND SPECIALTY PHARMACIES CBI 4TH ANNUAL FMV CONGRESS March 28, 2017 2017 HURON CONSULTING GROUP INC. SPEAKER INTRODUCTIONS John Moose, CPA, ABV Director
More informationInnovative Approaches to Saving Patients Money on Prescription Drug Costs
Innovative Approaches to Saving Patients Money on Prescription Drug Costs April 2018 1 Innovative Approaches to Saving Patients Money on Prescription Drug Costs Executive Summary As prescription drug prices
More information.COM. Pharmaceutical Brand Management Achieving Managed Care Pull-Through Performance
Pharmaceutical Brand Management Achieving Managed Care Pull-Through Performance www.healthcaremedicalpharmaceuticaldirectory.com Healthcare Medical Pharmaceutical Directory.COM Pharmaceutical Brand Management
More informationGross-to-Net Estimates and Accruals - Master Class
Gross-to-Net Estimates and Accruals - Master Class Mike Makovec, Audit Senior Manager, Deloitte & Touche LLP Walt Worsham, Senior Manager, Deloitte & Touche LLP Brad Schulte, Senior Manager, Deloitte &
More informationLAUNCH MANAGEMENT. Preparing for a Global Launch. Through Alignment, Communication, Collaboration and Transparency
LAUNCH MANAGEMENT Preparing for a Global Launch Through Alignment, Communication, Collaboration and Transparency Presented by: Lori Peters, QPharma, SVP Commercial Operations Ted Hoffman, Centerline Consulting,
More informationCBI 13th Annual Commercial Contract & Chargeback Excellence. Parsippany, NJ June 21-22, 2017
CBI 13th Annual Commercial Contract & Chargeback Excellence Parsippany, NJ June 21-22, 2017 Changing Dynamics Impacting the Commercial Pricing and Contracting Landscape 13 th Annual Commercial Contract
More informationIT S WHAT YOU CAN T SEE THAT HURTS YOU IS THE PHARMACEUTICAL INDUSTRY REPLACING EXISTING MEDICATIONS WITH MORE EXPENSIVE MEDICATIONS?
SPECIALTY DRUGS Many plan sponsors have had to make difficult and painful choices about how to spend pharmacy benefit dollars But now payors are once again challenged not just by extremely high costs but
More informationStatement on Drug Pricing in America: A Prescription for Change. Submitted to the Senate Finance Committee
Statement on Drug Pricing in America: A Prescription for Change Submitted to the Senate Finance Committee January 29, 2019 America s Health Insurance Plans (AHIP) is the national association whose members
More informationPrimary Competitive Intelligence in the Age of Specialty Pharmacy and Managed Care. Presented at: Date: Wednesday, September 26, 2018
Primary Competitive Intelligence in the Age of Specialty Pharmacy and Managed Care Presented at: Date: Wednesday, September 26, 2018 HIA was founded in 2018 by two doctors of pharmacy who are highly experienced
More informationStrategies for Forecasting and Grossto-Net (GTN) Estimates in a Fluid and Fast-Paced Environment
Strategies for Forecasting and Grossto-Net (GTN) Estimates in a Fluid and Fast-Paced Environment Gaining efficiencies through E2E Process Optimization March 21, 2016 1 Copyright 2016 Deloitte Development
More informationSpecialty Pharmacy: Talk the Marketing Talk Success Factors of Specialty Sales
Specialty Pharmacy: Talk the Marketing Talk Success Factors of Specialty Sales Kristen Akervik Sales Director, Sterling Specialty Pharmacy 1 Disclosure Kristin Akervik, Sales Director, Sterling Specialty
More informationDEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES DEMONSTRATING YOUR MEDICINE S VALUE TO ALL STAKEHOLDERS TRUSTED COMMERCIALIZATION AND MARKET ACCESS EXPERTISE WHEN COMMERCIALIZING A MEDICINE, IT
More informationDefining Strategic Metrics to Demonstrate Impact
The Value of Medical Affairs: Defining Strategic Metrics to Demonstrate Impact www.envisionpharmagroup.com The Value of Medical Affairs: Defining Strategic Metrics to Demonstrate Impact Objectives Establish
More information{ { { Bona Fide Service Fees and Fair Market Value. Managed Services Operations. Compliance & Risk Advisory Services. Business Intel Products
{ { { Managed Services Operations Compliance & Risk Advisory Services Business Intel Products Bona Fide Service Fees and Fair Market Value June 2015 Results from an Industry Survey CIS-PARTNERS.COM 2 BONA
More informationFederal Register /Vol. 72, No. 136 /Tuesday, July 17, 2007 /
Federal Register /Vol. 72, No. 136 /Tuesday, July 17, 2007 / 447.504 Determination of AMP. (a) AMP means, with respect to a covered outpatient drug of a manufacturer (including those sold under an NDA
More informationPreparing for product launch
Preparing for product launch A Finance Perspective CBI Conference September 28, 2017 Today s presenters Today s presenters Susan Garfield Principal Advisory, Life Sciences EY Bill Roberts Partner Northeast
More informationWebinar Series Physician Relations. Referral Development. Advancing the Physician Relations Program Structure
Webinar Series 2017 Physician Relations Referral Development Advancing the Physician Relations Program Structure Webinar Series 2017 Physician Relations Today s Agenda You will Learn: What are the right
More informationAdvanced Contracting Course
Advanced Contracting Course Stephanie Levin, AD, Commercial Data Acquisition & Scouting Bayer Healthcare Leslie Yendro, VP Business Development Avella Specialty Pharmacy Agenda Introduction Common Types
More informationTransparency Debate in PBM Industry Consumer Driven Healthcare Summit Sept , 2006 in Washington, DC. Marina Tackitt PBMI
Transparency Debate in PBM Industry Consumer Driven Healthcare Summit Sept. 13-15, 2006 in Washington, DC Marina Tackitt PBMI Session Objectives Summarize Complexity of Drug Benefit Management Define Concept
More informationNew Trends in the Use of Fair Market Value Concepts. PCF Disclosure, Transparency, and Aggregate Spend Conference February 6, 2014
New Trends in the Use of Fair Market Value Concepts PCF Disclosure, Transparency, and Aggregate Spend Conference February 6, 2014 Agenda Today s Speakers 4 Today s Discussion Topics 6 Question and Answer
More informationMARKET RESEARCH AT ADELPHI SEPTEMBER 2016
MARKET RESEARCH AT ADELPHI SEPTEMBER 2016 Adelphi Research conducts primary market research, exclusively in the healthcare industry Parent Company: Omnicom Group Providing full-service primary custom marketing
More information'Safe Harbor' For Preapproval Information Exchange To Get Legislative Push
Other Publications: Scrip Medtech Insight In Vivo Rose Sheet This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers,
More informationWORKSHOP B Monitor MSL and Field Force Compliance
WORKSHOP B Monitor MSL and Field Force Compliance Jeremy Lutsky Sr. Legal & Compliance Counsel Theravance Biopharma US, Inc. Alison Benincasa Associate Director, Specialty Markets Compliance Christine
More informationUS Pricing Basics and What to Expect from Healthcare Reform
US Pricing Basics and What to Expect from Healthcare Reform By Jack Mycka Applied Pharmacoeconomics and Outcomes Research Forum, UCSD Skaggs School of Pharmacy September 27, 2010 Agenda General pricing
More informationMaximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS
Maximizing Market Access: THE 5 MOST CRITICAL QUESTIONS TO ASK WHEN LAUNCHING A SPECIALTY DRUGS by Jan Nielsen, division president, Access & Patient Support Are You Asking the Right Questions? We ve all
More informationWendy Poirier, Director of Towers Watsons Canadian Health & Group Benefits Practice talks about the Canadian Rx Coalition
EXCLUSIVE INTERVIEW: Wendy Poirier, Director of Towers Watsons Canadian Health & Group Benefits Practice talks about the Canadian Rx Coalition Today I am pleased to interview Wendy Poirier Director of
More informationA High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges
A High-Touch Approach to Improving Patient Access Using field support to navigate reimbursement challenges For the brand and reimbursement teams who must develop commercial strategies for the biopharmaceutical
More informationSan Joaquin Valley Insurance Authority Prescription Drug RFP Analysis July 5 th, Michael E. Thomas, Pharm.D. V.P. National Pharmacy Management
San Joaquin Valley Insurance Authority Prescription Drug RFP Analysis July 5 th, 2012 Michael E. Thomas, Pharm.D. V.P. National Pharmacy Management PBM Information Pharmacy Benefit Management (PBM) Carve
More informationGallagher Healthcare Practice
Gallagher Healthcare Practice Keeping Your Organization in Good Health As the healthcare industry transitions from volume to value, you need a partner with access to a wide set of solutions that can be
More informationPrescription Drug Pricing. Page 1
Prescription Drug Pricing Page 1 Prescription Drugs As a Percent of Total National Health Expenditures, 1991-2014 12% 10% 8% 6% 4% 2% 0% 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
More informationImplementation of Pharmaceutical Policy Reform. Andreas Seiter Senior Health Specialist Access to Essential Medicine The World Bank
Implementation of Pharmaceutical Policy Reform Andreas Seiter Senior Health Specialist Access to Essential Medicine The World Bank Sector issues Critical sector for health outcomes Characterized by market
More informationPreparing Your Organization for a Medicare Advantage / Part D Compliance Audit
Preparing Your Organization for a Medicare Advantage / Part D Compliance Audit February 14, 2012 Today s Discussion Topics Introductions 2 CMS Audit Approach The Basics 4 A Deeper Dive 8 What to do when
More informationOIG Increases Auditing of Pharmaceutical Manufacturers: Coupons, Part D Remuneration and Medicaid Rebate Administration
For Discussion Purposes Only; Not Intended as Legal Advice. BEIJING BOSTON BRUSSELS CHICAGO DALLAS FRANKFURT GENEVA HONG KONG HOUSTON LONDON LOS ANGELES NEW YORK PALO ALTO SAN FRANCISCO SHANGHAI SINGAPORE
More informationIntroduction to the Generic Drug Supply Chain and Key Considerations for Policymakers
Association for Accessible Medicines Introduction to the Generic Drug Supply Chain and Key Considerations for Policymakers Key Takeaways Generic drugs play an important role in the U.S. health care system,
More informationRules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders
Rules of Engagement for MSLs - Appropriate Interactions with Internal and External Stakeholders Daniel Snyder, PhD Medical Director, Neurology North America Medical Affairs Ipsen Biopharmaceuticals, Inc.
More informationDynamic Prescriber Pull-Through Messaging Proven Effective at Growing Share
Dynamic Prescriber Pull-Through Messaging Proven Effective at Growing Share Targeted pull-through messages demonstrated to be more effective with increased frequency A PRECISION BRIEF Introduction Healthcare
More informationProvider Directory Data Quality Compliance Program
Provider Directory Data Quality Compliance Program Frequently Asked Questions February 2017 General Information 1. What is the Provider Directory Data Quality Compliance Program? In 2016, CMS mandated
More informationRoundtable Webinar. Presenters. April 6, Managed Care Contracting Risks: An Antitrust, Government Pricing and Fraud & Abuse Analysis
Roundtable Webinar Managed Care Contracting Risks: An Antitrust, Government Pricing and Fraud & Abuse Analysis April 6, 2017 Seth Lundy John Shakow John Carroll Presenters Seth Lundy +1 202 626 2924 slundy@kslaw.com
More informationMedical Pharmacy Trend Report: Managing the Trends and Complexity of Provider- Administered Drugs
Medical Pharmacy Trend Report: Managing the Trends and Complexity of Provider- Administered Drugs Thursday, March 10, 2016 1:00 2:30 EST 12:00 1:30 CST 11:00 12:30 MST 10:00 11:30 PST Casandra Stockman,
More informationPrescription Medicines: Costs in Context
Prescription Medicines: Costs in Context 2018 We are in a new era of medicine where breakthrough science is transforming care with innovative treatment approaches... Then Now Medicines made of chemical
More informationManaged Pharmacy Consultants, LLC
Managed Pharmacy Consultants, LLC 1 Who We Are A managed pharmacy consulting li firm Solely focused on the pharmacy benefit Privately owned and operated with no PBM affiliation Over 30 years of managed
More informationDiscover Your Leverage: A Value-Based Contracting Case Study
Discover Your Leverage: A Value-Based Contracting Case Study Doral Jacobsen, MBA, FACMPE, Chief Executive Officer Amanda Pritchett, MHA, Chief Executive Officer Prosper Beyond Inc., Asheville, N.C. Coastal
More informationDrugs, Dollars and Dynamics: The Ups and Downs of Generic Pharmaceutical Pricing. Presented by: Pharmacy Healthcare Solutions, Inc.
Drugs, Dollars and Dynamics: The Ups and Downs of Generic Pharmaceutical Pricing Presented by: Pharmacy Healthcare Solutions, Inc. Learning Objectives 1. Understand factors influencing generic pharmaceutical
More informationAligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy
October 2015 Aligning internal teams to secure buy-in from external stakeholders: a critical part of launch strategy The commercial success of a new pharmaceutical product depends on the buy-in of disparate
More informationPBMs: From RFP To Implementation. Christopher Cannon, NASTAD U.S. Virgin Islands ADAP and Georgia ADAP April 3, 2014
PBMs: From RFP To Implementation Christopher Cannon, NASTAD U.S. Virgin Islands ADAP and Georgia ADAP April 3, 2014 Webinar Etiquette Phone lines Lines will be muted until dedicated question time. Please
More informationBeyond Infographics: Contextual Factors in Healthcare MR. Thomas M. Richardson PhD, MBA, PA-C Sr. Vice President Consulting, KJT Group, Inc.
Beyond Infographics: Contextual Factors in Healthcare MR Thomas M. Richardson PhD, MBA, PA-C Sr. Vice President Consulting, KJT Group, Inc. Agenda 03 14 17 30 Market Research Level Set Define Contextual
More informationEvaluating Payer Opinion versus Behavior for Better Decision Making
Evaluating Payer Opinion versus Behavior for Better Decision Making Elizabeth Sampsel, PharmD, MBA, BCPS Vice President, Payer Strategy and Relations, Dymaxium, Inc. Allen Lising Chief Executive Officer,
More informationA COMPLIANCE SOLUTION DESIGNED TO HELP PLANS MEET CMS REQUIREMENTS
A COMPLIANCE SOLUTION DESIGNED TO HELP PLANS MEET CMS REQUIREMENTS Founded on the Common Conditions, Improvement Strategies, and Best Practices based on 2013 Program Audit Reviews HPMS memo, dated August
More informationGeneric Pricing and Contract Analytics
Generic Pricing and Contract Analytics May 2017 Tom Evegan Tom.evegan@cumberlandcg.com 732-614-3350 2 Agenda I. Analytics: Keys to Accuracy and Compliance a) Roadmap and Work Steps b) Dashboards and Big
More informationBuild a deeper appreciation and understanding of HTA needs into your wider organization. Stefan Holmstrom
Build a deeper appreciation and understanding of HTA needs into your wider organization Stefan Holmstrom Executive Director HEOR Medical Affairs, Global Astellas Pharma 1 Outline of presentation 1. Changing
More informationImportant Prescription Benefit Information
Important Prescription Benefit Information Prepared Exclusively for: Wichita Center for Graduate Medical Education HDHP Plan medtrakrx.com Welcome to MedTrakRx Dear Member: This booklet contains important
More informationFaster, Better, Smarter Marketing to Win
Faster, Better, Smarter Marketing to Win presented by Irving L. Stackpole, RRT, MEd 1 OBJECTIVES Describe three (3) ways that LTC providers can use speed to differentiate themselves. List the two (2) methods
More informationFinding the Balance between Clinical & Commercial Key Roles. Stewart Geary Chief Medical Officer, Senior Vice President, Eisai, Japan
IBC LIFE SCIENCES Part of: 4 TH ANNUAL Grand Copthorne Waterfront Hotel, Finding the Balance between Clinical & Commercial Key Roles Expert Faculty Include: Ajay Tiku Vice President Medical, Asia Pacific,
More informationUnderstanding Payer Dynamics. A critical factor in maximizing brand performance. Healthcare Measurement IMS Payer Insights
Understanding Payer Dynamics A critical factor in maximizing brand performance Healthcare Measurement IMS Payer Insights Understanding Payer Dynamics A critical factor in maximizing brand performance In
More informationAuditing: A Panel Discussion of Evolving Compliance Strategies
Auditing: A Panel Discussion of Evolving Compliance Strategies Ann E Lewis, VP and Senior Counsel, US Healthcare Law Compliance (Bristol-Myers Squibb) Monica Jonhart, Director, Auditing, US Healthcare
More informationSteve Clark Senior Vice President
Steve Clark Senior Vice President 1 Collaborations Opportunity for life sciences companies Partner with Optum & United leadership to design and pilot high-impact programs Close key gaps in care to improve
More informationPhysician E/M Audit Problems and Effective Solutions
Physician E/M Audit Problems and Effective Solutions Lamon Willis Director of Business Development Healthicity CPCO, CPC-I, COC, CPC Agenda 1. Setting Up Your Audits 2. Audit Resources 3. Auditing Methodology
More informationIdentifying Critical Factors Pre-launch
Identifying Critical Factors Pre-launch Incorporate pricing and market access into product planning Eric M. Bachman, Director Boston office One Canal Park Cambridge, MA 02141, USA Tel. +1 617 231 4592
More informationMedicare Advantage risk adjustment: How deep is the well?
Medicare Advantage risk adjustment: How deep is the well? With increasing regulation and focus on quality, comprehensive risk and quality programs are more important than ever. Whether you re engaging
More informationSocial Media in Healthcare Leverage Social Media for Real Business Impact
Social Media in Healthcare Leverage Social Media for Real Business Impact Gelb Consulting, An Endeavor Management Company 2700 Post Oak Blvd P + 281.759.3600 Suite 1400 F + 281.759.3607 Houston, Texas
More informationPRESCRIBING GROWTH IN PHARMA WITH DATA SCIENCE
PRESCRIBING GROWTH IN PHARMA WITH DATA SCIENCE By Troy Andre, Ethan Dabbs, Roman Geis, Erin George, and Martha Pease In an increasingly dynamic environment, pharma brand teams frequently struggle to gain
More informationPrescription Medicines: Costs in Context
Prescription Medicines: Costs in Context 2017 We are in a new era of medicine where breakthrough science is transforming care with innovative treatment approaches... Then Now Medicines made of chemical
More informationMapping the Patient Journey: Harnessing the power of big data and analytics A FirstWord ExpertViews Dossier Report
AM PL E PA G ES S A S G ES data and analytics A FirstWord ExpertViews Dossier Report Published Copyright 2016 Doctor s Guide Publishing Limited All rights reserved. No part of this publication may be reproduced
More informationA GUIDE TO PROCURING MARKETING ANALYTICS & CONSULTANCY
A GUIDE TO PROCURING MARKETING ANALYTICS & CONSULTANCY THE LONG-TERM EFFECTS OF ADVERTISING 2 // A GUIDE TO PROCURING MARKETING ANALYTICS AND CONSULTANCY SETTING UP MARKETING SOURCING AND PROCUREMENT PROFESSIONALS
More informationChargeback Adjudication for 340B Contract Pharmacies
Chargeback Adjudication for 340B Contract Pharmacies June 21 st 2017 Kunal Akwalia, Senior Manager, Highpoint Solutions Agenda Key Terms Impactful Challenges Current State Other Considerations What information
More informationPrescription Medicines: Costs in Context
Prescription Medicines: Costs in Context 2018 We are in a new era of medicine where breakthrough science is transforming care with innovative treatment approaches... Then Now Medicines made of chemical
More informationPharmaceutical Compliance Congress: Pricing Update
Pharmaceutical Compliance Congress: Pricing Update November 3, 2011 Jeffrey L. Handwerker Agenda Medicaid Drug Rebate Program OIG Work Plan Draft FULs AMP vs. ASP Comparisons NADAC Survey 340B Program
More informationPhysician Marketing & Outreach Growing Referring Physician Lifetime Value
Growing Referring Physician Lifetime Value Gelb, An Endeavor Management Company 1011 Highway 6 South P + 281.759.3600 Suite 120 F + 281.759.3607 Houston, Texas 77077 www.gelbconsulting.com Overview Today
More informationYASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA.
YASHAJIT SAHA & ABHISHEK SHARMA, SUBJECT MATTER EXPERTS, RESEARCH & ANALYTICS ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN PHARMA wns wns ADVANCED ANALYTICS: A REMEDY FOR COMMERCIAL SUCCESS IN
More informationSPECIALTY PHARMACY : ARE YOU MISSING OUT ON A VIABLE REVENUE STREAM. January 16, 2018
SPECIALTY PHARMACY : ARE YOU MISSING OUT ON A VIABLE REVENUE STREAM January 16, 2018 Agenda Defining Specialty Pharmacy and its revenue trends Rationale for the immense growth and how to leverage the cost
More informationWhen customers are the cure
Life Sciences Of special interest to Chief financial officers Chief diversity officers Chief scientific officers Chief innovation officers Chief development officers Insights for 5executives When customers
More informationChallenges and Opportunities in Pharma: Perspective for an Emerging Middle East April 24th, 2015
Challenges and Opportunities in Pharma: Perspective for an Emerging Middle East 2020 April 24th, 2015 Content Pharma Market Landscape Global Pharma Market Market Categories Middle East Markets Major Challenges
More informationThe New Age of IDNs. Six Reasons to Sharpen Your Strategy
The New Age of IDNs Six Reasons to Sharpen Your Strategy Many pharmaceutical companies struggle to figure out the right level of investment in creating and executing an IDN strategy. If your organization
More informationOff-Label Promotion: Risks, Controls and Assessment
7 th th Annual National Pharmaceutical Congress November 9, 2006 Off-Label Promotion: Risks, Controls and Assessment John T. Bentivoglio Co-Leader FDA/Healthcare Group jbentivoglio@kslaw.com 202.626.5591
More informationBIOTECH, MED DEVICE & PHARMA
WHITEPAPER Key Account Management Strategies for BIOTECH, MED DEVICE & PHARMA INTRODUCTION Changes in the healthcare landscape have led to changes in customers. In an environment where healthcare providers
More informationGain Insights for a World-Class Global Monitoring Program
Gain Insights for a World-Class Global Monitoring Program Presented by: Carrie Ann Ashcom, Director Global Compliance, Zimmer Biomet February 8, 2017 Philadelphia, PA 1 Focus Develop standardized monitoring
More informationImplementing a Compliance Monitoring Program. January 29, 2014
Implementing a Compliance Monitoring Program January 29, 2014 1 Agenda 1. Mission and Purpose 2. Scope 3. Situational Analysis 4. Best Practices 5. Questions Mission and Purpose 3 Mission and Purpose Mission
More informationJuly 13, Dear Secretary Price:
July 13, 2017 The Honorable Thomas E. Price, M.D. Secretary U.S. Department of Health and Human Services 200 Independence Avenue, SW Washington, DC 20201 Dear Secretary Price: At our meeting on May 16,
More informationHow to Write a Winning RFP for Healthcare Website Redesign
How to Write a Winning RFP for Healthcare Website Redesign Helpful tips to guide healthcare marketers before you embark on the RFP process. ccording to recent research, the average healthcare organization
More informationTransparency as a Good Business Practice
Transparency as a Good Business Practice Exploring How Transparency Can Drive Best Practices in Business Strategy August 2017 Polaris Management Partners Agenda Compliance Trends 2017-2018 Deriving Strategic
More informationTen Overlooked Opportunities For Significant Performance Improvement and Cost Savings
Ten Overlooked Opportunities For Significant Performance Improvement and Cost Savings Ten Overlooked Opportunities For Significant Performance Improvement and Cost Savings Huron Healthcare s Performance
More informationEffective Negotiations
Why Negotiations? We desire a different situation There are better options available Save money, make more money Business success Because the boss asked us to There is something we want Opportunities for
More informationFrom Volume to Value: Using payer insights to increase sales effectiveness
From Volume to Value: Using payer insights to increase sales effectiveness by Anita Burrell The collective will of the provider community has moved to acquiescence to the payer will controlling costs and
More information5 Best Practices to Optimize a Sales Call
5 Best Practices to Optimize a Sales Call Pharmaceutical sales is a job that demands endless creativity and planning. Reps have an average of 2-3 minutes to convince doctors that their drug is the best
More informationBrand Plan Sample Template. Akademia Marketingu Farmaceutycznego
Brand Plan Sample Template Akademia Marketingu Farmaceutycznego Key Marketing Questions 1. 1 What is the basic definition of your market? 2. 2 Who are your target audiences in the marketplace? 3. 3 What
More informationInnovations in Drug Pricing and Reimbursement:
ADVISORY REPORT AM PL E PA G ES S A S G ES A FirstWord Dossier Advisory report and Reimbursement Published Copyright 2016 Doctor s Guide Publishing Limited Part of the FirstWord Dossier family of reports
More informationTAKE A CLOSER LOOK at Biosimilars
Key Stakeholders Frequently Asked Questions Executive Summary Understanding Biosimilars Potential Benefits of Biosimilars TAKE A CLOSER LOOK at Biosimilars 2018 Trends in Biosimilars Report Message From
More informationPowering the Life Sciences Commercial Engine with Market Access Insights
Powering the Life Sciences Commercial Engine with Market Access Insights April 2017 CONTENTS 1. Introduction 3 2. The Race for Market Access Insights has Begun 4 3. Life Sciences is Not Yet Firing on All
More informationKey Takeaways from the Winter 340B Coalition Conference
Key Takeaways from the Winter 340B Coalition Conference Kristin Fox-Smith, MPA Douglas E. Miller, PharmD Tony Zappa, PharmD, MBA February 25, 2016 1 Visante Structure Founded in 1999 to provide pharmacy-related
More informationMEANINGFUL USE CRITERIA PHYSICIANS
MEANINGFUL USE CRITERIA PHYSICIANS The first list is of the 25 Stage 1 Meaningful Use criteria for eligible providers (EP) and comes from the proposed rule: "Medicare and Medicaid Programs; Electronic
More informationBest Practices in EHR Implementations
WHITE PAPERS FOR REAL PEOPLE Best Practices in EHR Implementations by TIM LIDDELL VICE PRESIDENT, PROVIDER DEPLOYMENT BETSY CROSS DIRECTOR, PROVIDER DEPLOYMENT CONTENTS The SaaS Delivery Model... 1 January
More informationAmgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers, secondees and temporary staff worldwide ( Covered Persons ). Consultants, contract
More informationTotal. Innovation Networking Professional Development
2016 2017 February February 9 & 10, 10, 2017 2016 San San Francisco Francisco, CA Total User Customer Experience Experience Customer Experience Planning Customer Experience Planning Aligning CX, UX and
More informationPharmacy 201 Session 2
Pharmacy 201 Session 2 Session 1 Assignment 1 Does the Client/Prospect Have a Pharmacy Contract? 2 How Long is the Term of the Contract or Agreement? 3 Is the Client/Prospect currently in a carved-in or
More informationReal-Life Strategies for Account Managers to Help Grow Market Share
1 CMR Institute 2017. All Rights Reserved. Real-Life Strategies for Account Managers to Help Grow Market Share As an account manager, understanding your customers challenges including their performance
More informationMONTEFIORE HEALTH SYSTEM
COVER STORY MONTEFIORE HEALTH SYSTEM www.montefiorehealthsystem.org / Annual revenue: $4 billion / Headquarters: Bronx, N.Y. / Employees: 22,314 / Charles Agins, vice president of finance: We want to add
More information2018 Media Kit.
2018 Media Kit www.drugchannels.net Learn more about reaching the Drug Channels community: Paula Fein, M.S.Ed. V.P., Business Development, Drug Channels Institute paula@drugchannelsinstitute.com Adam is
More informationHCCA Audit & Compliance Committee Conference. February 29-March 1, Drivers of ERM. Enterprise Risk Management in Healthcare.
Enterprise Risk Management in Healthcare Deloitte & Touche LLP Heather Hagan, Senior Manager Nancy Perilstein, Senior Manager February 29, 2016 Discussion Items Drivers of Enterprise Risk Management (ERM)
More informationTHE VALUE OF STRATEGIC SOURCING FOR PROCUREMENT PROFESSIONALS
THE VALUE OF STRATEGIC SOURCING FOR PROCUREMENT PROFESSIONALS UNDERSTANDING STRATEGIC SOURCING Maximizing value while minimizing cost is a business imperative across every discipline within organizations.
More information